Anemia after renal transplantation
Conditions
Interventions
Roxadustat treatment group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing primary allogeneic renal transplantation in our hospital; 2. Aged 18–65 years old; 3. Patients diagnosed with post-renal transplant anemia (diagnostic criteria: Hb <13 g/dL in males and Hb <12 g/dL in females after renal transplantation).
Exclusion criteria
Exclusion criteria: 1. Patients complicated with hematological diseases such as thalassemia and aplastic anemia; 2. Patients with uncorrected nutritional anemia; 3. Renal transplant recipients with ABO-incompatible transplantation; 4. Recipients complicated with delayed graft function (DGF) after surgery; 5. Patients with a history of malignancy or autoimmune diseases; 6. Patients unable to complete regular follow-up in our hospital or with incomplete laboratory data; 7. Patients undergoing re-transplantation of the kidney; 8. Patients complicated with gastrointestinal bleeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hb level; | — |
Secondary
| Measure | Time frame |
|---|---|
| red blood cell count;reticulocyte count;hematocrit;eGFR;Nucleated Red Blood Cell;Red Cell Distribution Width;Folic acid;Albumin;parathyroid hormone;Vitamin B12;Erythropoietin;Serum Iron;transferrin;total iron binding capacity;Ferritin;C-reactive protein;IL-2;IL-6;IL-1 ß;TNF- a;T cell subsets;BKV;CMV;EBV; | — |
Countries
China
Contacts
Public ContactYunying Shi
West China Hospital, Sichuan University
Outcome results
None listed